The requisite endpoint of mammalian oocyte maturation, whether in vivo or in vitro, is a metaphase II oocyte which is able to be fertilized and which can eventually support normal embryonic development. Oocytes which have been matured in vivo basically fulfil these criteria. On the other hand, a completely different situation exists when these cells are isolated from the ovaries and cultured in vitro. If they are too small (growing oocytes), they do not undergo maturation, or, if more advanced, will mature only to the metaphase I stage. Even in fully grown oocytes which are able to mature to metaphase II, the developmental potential after fertilization is disappointingly low, for reasons which remain unknown. The complexity of certain factors (nuclear, cytoplasmic or arising from our current culture systems) undoubtedly influences both the ability of oocytes to mature fully, as well as their developmental potential after fertilization.
Introduction
Oocyte maturation is a complex process involving both the progression of the meiotic cycle and the reprogramming of cytoplasmic events. The endpoint of maturation in vivo is the release from the follicle of a mature (metaphase II) oocyte with the competence to support normal embryonic development. Ovulation is followed by sperm penetration, egg activation, the completion of meiosis and entry into mitosis. Meiotic maturation of mammalian oocytes in vitro was first described in rabbits by Pincus and Enzmann in 1935. In the ensuing 60 years, numerous papers have been published on the maturation of oocytes in vitro. The overwhelming bulk of these papers reports that oocytes aspirated from large antral follicles of many species readily progress to metaphase II in culture and undergo fertilization in a high percentage of instances. Their developmental potential after fertilization is, however, disappointingly low. Thus it is clear that conditions in vitro are greatly inferior to those in vivo for reasons that are not fully understood. The only exception is the mouse, where conditions for in vitro maturation are almost equivalent to exogenous gonadotrophin-induced maturation in vivo (Schroeder and Eppig, 1984) . In this review we shall argue that the ability to progress through meiosis is acquired only after the nucleus and cytoplasm have completed parallel developmental programmes during the growth phase. We shall thereafter highlight and explore the reasons for the large *To mark his 70th year we dedicate this review to Josef Fulka Senior who is honoured not only as one of the founders of modern oocyte biology but also for single-handedly maintaining the international reputation of Czechoslovakian developmental biology during the 1960s and 1970s.
differences that exist in mammals in the time taken to complete the transition from the germinal vesicle (GV) to the metaphase II (MII) stage. Finally we shall discuss the nature of checkpoint mechanisms in oocytes and the degree to which these prevent meiotic progression in oocytes whose DNA is damaged or whose cytoplasmic development is incomplete.
Oocyte growth phase

Morphological changes during oocyte growth
The mammalian ovary contains a large reservoir of inactive germ cells present in primordial follicles and two broad categories of oocytes. The first group consists of growing oocytes that are unable to respond to maturation signals in vivo or in vitro and remain arrested in diplotene stage or, if more advanced, progress only to metaphase I. The second or socalled fully grown group of oocytes respond to gonadotrophic signals and mature to metaphase II in preovulatory follicles and in culture. The transition from the first to the second phase is complex and involves structural and biochemical changes in both the cytoplasmic and nuclear compartments.
Structural changes in the cytoplasm, described in detail elsewhere (Knobil and Neill, 1988) , include an increase in the number and a change in the morphology of mitochondria, ultrastructural modification to the Golgi complex, an accumulation of ribosomes and, in some species, an increase in latticelike structures. The most predominant nuclear change is associated with the nucleolus which undergoes a transition from a diffuse, reticulated configuration (fibrillogranular network) to a dense, uniform body composed of exclusively fibrillar material. These modifications reflect the period of intensive RNAs (hnRNA, mRNA and rRNA) synthesis which gradually ceases as the oocytes grow. As shown by Albertini (1992) , other important changes include specific modifications to the chromatin. This is rather diffuse in the nuclei of growing mouse oocytes when compared with the compact state of the chromatin surrounding the nucleolus in fully grown oocytes which are competent to mature. Similarly, the centrosome/ microtubule complex is specifically modified as oocytes become competent to mature. Growing oocytes show an interphase array of long microtubules, whilst competent oocytes contain 1-5 microtubule organizing centres (MTOC) in a perinuclear position. Changes in the location of the MTOCs during maturation correlate closely with changes in centrosome phosphorylation (Wickramasinghe and Albertini, 1993) .
Biochemical changes during oocyte growth
The biochemical events that underpin growth and structural reorganization in oocytes have been the subject of several extensive reviews (Masui and Clarke, 1979; Browder, 1985) . A particularly novel feature of the biosynthetic machinery during oocyte growth is the capacity to sequester selectively certain classes of mRNA by processing them into ribonucleoprotein particles (Davidson, 1986; Spirin, 1994) . In this packaged form, the maternal mRNA is protected against nucleolytic degradation and remains stored in the cytoplasm until recruited for translation by special signals generated either during maturation or in early development. The specialized characteristics of RNA-binding proteins involved in the formation of mRNPs in growing oocytes provide one important focus for future research. Equally the sequence specialization in the 5Ј-and 3Ј-untranslated regions (UTRs) of stored messenger RNAs provides a complementary research focus. The importance of understanding these mechanisms is underlined by the fact that a major cause of failure during maturation results from inappropriate storage, recruitment and poly-A tail processing of maternal mRNA (Brevini Gandolfi et al., 1997) . It is also essential to examine how these processes are influenced by our current culture systems.
Differences in the central cell cycle regulatory molecules in growing and fully-grown oocytes offer a further important area of biochemical focus. Whilst much of the current information on meiotic regulation during oocyte growth is still fragmentary, interesting species variations are becoming apparent. The most detailed analyses of growth related changes in cell cycle molecules have been carried out on mouse oocytes.
The synthesis and accumulation of p34 cdc2 , the central catalytic subunit of maturation promoting factor (MPF) in growing mouse oocytes correlates closely with the ability of these cells to undergo germinal vesicle breakdown (GVBD) in vivo or in vitro or after treatment with okadaic acid, which inhibits protein phosphatase 2A, thereby activating cdc25 and enhancing MPF activity (Chesnel and Eppig, 1995; de Vantery et al., 1996) . On the other hand, the content of cyclin B reaches maximal levels in oocytes not yet competent to undergo GVBD. Interestingly, p34 cdc2 levels also increase in cultured granulosa-free oocytes without a concomitant ability to undergo GVBD (Chesnel and Eppig, 1995) . These observations raise the possibility that factors other than p34 cdc2 synthesis and 42 accumulation may be the central determinants in the acquisition of meiotic competence in growing mouse oocytes. This hypothesis has been confirmed recently by de Vantery et al. (1997) who microinjected translatable p34 cdc2 mRNA into incompetent mouse oocytes. This yielded high levels of the protein but did not lead to GVBD. A similar situation was observed after the injection of cyclin B1 mRNA. The induction of GVBD was only possible when both p34 cdc2 and cyclin B1 mRNAs were injected into oocytes. The authors suggested that a posttranslational event must occur to achieve meiotic competence in mouse oocytes.
In the pig, different mechanisms appear to block meiotic progression at different stages of oocyte growth. The measurement of cell-cycle molecules in small oocytes (Ͻ80 µm) isolated from preantral follicles revealed that the p34 cdc2 subunit of MPF, is rate limiting at this early stage of growth (Hirao et al., 1995) . As growth progresses (90 µm diameter) concentrations of both the p34 cdc2 catalytic subunit and the cyclin B regulatory subunit are present at levels comparable with those of fully grown oocytes . The meiotic block in these more advanced stages of growth is imposed by a series of lesions in the phosphorylation cascade which is involved in the conversion of the inactive pre-MPF complex to an active form (Christmann, 1994) . Confirmation of these biochemical results was obtained by treatment of oocytes at the small (Ͻ80 µm) and intermediate (~90 µm) growth phases with okadaic acid. Whilst okadaic acid was unable to induce meiotic progression in the Ͻ80 µm oocyte category (no p34 cdc2 in these oocytes) it was an effective activator of 90 µm oocytes (p34 cdc2 and cyclin B present in this larger oocyte category). The rat, like the pig (90 µm size category), contains comparable amounts of the catalytic and regulatory subunits of MPF in both growing and fully grown oocytes (Goren and Dekel, 1994) . However, the possibility that the mechanisms involved in the acquisition of meiotic competence in mouse oocytes might differ fundamentally from those of other species cannot be discounted. For example, the indirect indication is that fully grown (competent) mouse oocytes, unlike those of other mammals (rat, pig, sheep, cow) undergo the G 2 -to M-phase transition with no requirement for new protein synthesis (Fulka et al., 1986a; Moor and Crosby, 1986; Knobil and Neill, 1988; Simón et al., 1989) .
Penultimate events in the acquisition of meiotic competence
Interestingly, progression from the incompetent to the competent state during oocyte growth does not occur abruptly but includes an intermediate stage during which meiosis progresses to metaphase I but not to anaphase. When metaphase I-arrested mouse oocytes are fertilized or parthenogenetically activated their chromosomes decondense, a pronucleus forms and triploid blastocysts develop from fertilized eggs (Eppig et al., 1994) . Thus we may conclude that cytoplasmic rather than nuclear differentiation influences meiotic progression in oocytes during the penultimate stages of growth. That the GV plays a role parallel to that of the cytoplasm in conferring full competence on these oocytes has however, recently been demonstrated by the introduction of incompetent GV nuclei into cytoplasts prepared from fully grown mouse immature oocytes (Kono et al., 1996) . Although the reconstructed oocytes progressed to metaphase II they were subsequently totally unable to support either normal sperm decondensation or male pronuclear formation. When metaphase II plates from reconstituted oocytes were retransferred to cytoplasts prepared by the enucleation of normal metaphase II oocytes then both decondensation and pronuclear formation occurred in a normal manner. The importance of these elegant experiments is that they demonstrate with clarity that differentiation events in both the cytoplasmic and nuclear compartments are essential for the acquisition of meiotic competence in mouse oocytes. However, it is not known if the same situation exists in other mammalian species.
The above conclusions are supported by earlier experiments in which fully grown competent oocytes were fused to incompetent growing oocytes. It was shown that when an immature growing oocyte was fused to a fully grown GVstaged oocyte (mouse, pig) maturation was blocked in these giant cells and both germinal vesicles remained intact (Fulka, 1985; Fulka et al., 1985) . As a result of fusion the high levels of RNA synthesis which typify intact growing oocytes abruptly ceased and the nucleolus was partially transformed into the more compacted form. The activity responsible for blocking the onset of maturation was termed maturation inhibiting activity (MIA) but its chemical nature remains unknown.
In the mouse, when a growing oocyte is fused to a fully grown metaphase oocyte it responds to the high levels of MPF by undergoing GVBD and premature chromatin condensation (Balakier and Czolowska, 1977) . Whilst single growing oocytes respond to MPF when fused to single fully grown M-phase oocytes the situation is reversed when several growing oocytes are fused to a single maturing metaphase I oocyte. In these instances, the nuclear membranes of the growing oocytes remain intact whilst the metaphase I chromosomes from the maturing oocyte form a cluster of chromatin which ultimately becomes membrane-bound (Fulka et al., 1986b) . Until the interactions between MIA, MPF and other factors in multinucleate giant oocytes are elucidated, it appears premature to speculate on reasons why membrane disassembly is prevented in these combinations. However, much remains to be discovered about the molecular mechanisms that confer on oocytes the ability not only to complete meiosis but more importantly to support full embryonic development after fertilization. Certainly the clarification of these interactions would be extremely useful for experiments involving the in-vitro culture of small follicles or incompetent oocytes.
Is a final component required for developmental competence to be conferred after oocytes have become fully grown?
We postulate that the acquisition of full developmental competence may extend beyond the growth phase and involves instead pre-maturation changes in the fully grown oocyte. Whilst evidence for this concept is still largely circumstantial it is nevertheless clear that oocytes in pre-ovulatory follicles are exposed, during the late follicular phase, to substantial increases in gonadotrophin, growth factor and oestrogen con-43 centrations before luteinizing hormone (LH) release and the resultant induction of maturation. The possibility that the follicular phase represents a period of pre-maturation development is supported by the results of Assey et al. (1994) who identified a series of morphological changes in the nucleus and cytoplasm of fully grown bovine oocytes in dominant follicles before the release of LH. Moreover, the influence of some other factors cannot be ruled out, as demonstrated recently for leptin by Cioffi et al. (1997) . The better understanding of these changes and factors could help us to modify our in-vitro culture systems and produce oocytes which are developmentally equivalent to those matured in vivo.
The G 2 -to M-phase transition in fully grown oocytes Background
The molecular events that regulate meiotic progression in fully grown oocytes have been the subject of a large number of papers and recent reviews (Choi et al., 1991; Kobayshi et al., 1991; Gautier and Maller, 1991; Katsu et al., 1993; Naito et al., 1995; Sagata, 1996) . In summary, meiosis is driven by a MPF-kinase complex consisting of both a cyclin regulatory subunit and a p34 cdc2 catalytic subunit derived from the cdk family of tyrosine kinases (Nurse, 1990) . Progression from the G 2 -to M-phase in most mammalian oocytes requires either or both the synthesis of cyclin B2 and its relocation from the cytoplasm to the nucleus together with the dephosphorylation of key residues on the catalytic subunit (Naito et al., 1995) . This dephosphorylation event, which involves the removal of phosphates from Thr 14 and Tyr 15 of the p34 cdc2 molecule, is catalysed by a phosphatase encoded by the cdc25 gene and is a key event in the conversion of inactive or pre-MPF into active MPF kinase (see Izumi and Maller, 1993 for references) . Whilst the central cell cycle machinery is highly conserved in animals and plants its precise mode of operation varies. This variation is well illustrated by differences that exist in the regulation of the G 2 -to M-phase transition in the oocytes of mice and many other species. For example, entry into metaphase in mouse oocytes is totally inhibited by an increase in intracellular cyclic AMP levels caused either by the inhibition of cyclic nucleotide phosphodiesterase by isobutyl methyl xanthinine (IBMX) or by incubating G 2 -stage oocytes in medium containing dibutyrylcyclic adenosine monophosphate (dbcAMP). Bovine oocytes on the other hand are unaffected by the presence of either inhibitor and proceed to metaphase in an uninterrupted manner. When a single immature bovine oocyte was fused to a single immature mouse oocyte the onset of maturation (GVBD) was not prevented in the presence of dbcAMP. IBMX was more potent and nearly 50% of giant cells contained intact GVs. Moreover, nearly all GVs were well preserved in the presence of dbcAMP or IBMX when a single bovine GV oocyte was fused to several mouse GV oocytes . These results indicate that the mechanisms leading to the initiation of oocyte maturation in different mammalian species are not identical and a detailed analysis is necessary to explain these differences.
Passage from metaphase I to anaphase occurs after ubiquitin-mediated proteolysis of cyclin molecules (Kobayashi et al., 1991) . The formation of the second metaphase again requires high levels of active MPF-kinase production. A c-mos protooncogene product Mos is able to induce stabilization of MPFkinase and hence arrest cell cycle progression at metaphase II; sperm penetration and the resultant increase in oocyte intracellular Ca 2ϩ concentrations induce cyclin degradation and the completion of the meiotic cycle (Sagata, 1996) .
Variations in the pre-metaphase interval
An interesting but unresolved question arising from studies on meiosis is why the time taken to progress from the G 2 phase to the second metaphase stage varies so widely between species. Clear example of this are the mouse, rat and rabbit oocytes that require 10-12 h, the bovine oocyte that requires 20 h and the pig oocyte that requires 36-40 h to reach metaphase II. Cell fusion studies have been used to determine whether the rate of meiotic cycle progression is regulated by the cytoplasm, the nucleus or by a combination of both. The results show that in all fusion combinations (pigϫrabbit) the time required to undergo GVBD is determined by components in the oocyte fusion partner with the shortest interval to membrane breakdown (Fulka, 1983) .
Three further experiments were carried out to determine whether the primary signal for GVBD originates from the cytoplasm or the nucleus. In the first series of experiments oocytes from the mouse and bovine were cultured in cycloheximide to block protein synthesis. Mouse oocytes are insensitive to cycloheximide treatment and undergo GVBD in the presence of the inhibitor, whilst meiotic progression in bovine oocytes is invariably blocked by the drug. When giant oocytes (mouseϫbovine) were cultured in cycloheximide-containing medium, one of the following events occurred: (i) neither the bovine nor the mouse nuclei underwent GVBD (71%); (ii) only the mouse nuclei underwent GVBD and the bovine nuclei remained intact (16%); or (iii) both nuclei underwent GVBD (13%).
In the second series of experiments pig and mouse karyooplasts containing the GV with minimal cytoplasmic contamination were fused to intact GV oocytes from the opposite species (see Figure 1) . In control giant cells produced by fusion of one immature mouse oocyte to one immature porcine oocyte no intact GVs could be detected after 6 h in culture. When pig karyoplasts were introduced into mouse oocytes both sets of nuclei underwent GVBD within 6 h. In contrast, no GVBD occurred within 6 h when mouse karyoplasts were fused to pig oocytes. An obvious conclusion from these combined results is that the timing of GVBD is under cytoplasmic control with little or no contribution from the nucleus. That this interpretation is incorrect is shown by the results of the third series of experiments in which enucleated mouse oocytes (cytoplasts) were fused to pig oocytes. In this combination no acceleration of GVBD was detected even 10 h after fusion. The probable involvement of the nucleus and chromosomes in meiotic cycle regulation is further supported by experiments in which mouse oocytes at the GV stage (shortly after GVBD or at metaphase II stage) were bisected and cultured. Whilst MPF was initially present in both halves, degradation of the kinase complex occurred much more rapidly in the enucleated half than in the nucleated half (Balakier and Masui, 1986; Czolowska et al., 1986) . We postulate therefore that the differing lengths of time required by different species to undergo GVBD reflect primarily the time required to activate pre-MPF (mouse) or to synthesize new regulatory subunits of MPF (ungulates and primates). This cytoplasmic regulation is, however, heavily modulated by nuclear components which determine the stability of the MPF-complex.
Other factors frequently not taken into consideration include the nucleocytoplasmic ratio; i.e. the ratio of cytoplasmic to nucleoplasmic volume. In a third series of experiments aimed at examining the effect of this ratio on maturation of mouse oocytes, we produced by bisection nucleated oocytes containing half, third, quarter or trace amounts of cytoplasmic volume (see Figure 2 ). These modified oocytes were cultured in vitro and the onset of GVBD and the capacity for polar body extrusion was determined. Half oocytes showed basically the same pattern of GVBD as intact cells. The frequency of polar body extrusion was slightly lower compared with intact oocytes. In oocytes with a third of the normal cytoplasmic volume the onset of GVBD was delayed by~2 h but the frequency of polar body extrusion appeared to be lower (80 versus 58%) compared with intact oocytes. One quarter oocytes underwent GVBD with a longer delay than one third oocytes (4 h) but they rarely extruded polar bodies and a metaphase I-like stage was typically observed in the cytoplasm. Moreover, these metaphases differed from those found in normal oocytes by the presence of apparently normal spindles but chromosomes which formed a more compact mass. Karyoplasts prepared with a very thin rim of cytoplasm surrounding the nucleus rarely underwent nuclear envelope breakdown. Instead, the nuclei remained intact but contained heavily condensed chromatin surrounding the nucleolus. The presence of a reduced nucleocytoplasmic volume resembles the situation in growing oocytes in which the ratio of cytoplasmic to nucleoplasmic volume increases during oocyte growth, while these oocytes concomitantly acquire the ability to undergo GVBD (Knobil and Neill, 1988) . As mammalian oocytes are frequently used for different manipulative techniques (e.g. cytoplasmic transfer, cloning) these factors must be also considered.
Cell cycle checkpoints G 2 -to M-stage transition checkpoints
Cell cycle checkpoints are defined as mechanisms that control the order and timing of cell cycle transition and ensure that critical events such as DNA replication and chromosome separation are completed correctly (Elledge, 1996) . Whilst checkpoint controls are a dominant aspect of cell cycle regulation in virtually all somatic cells, it appears likely that oocytes and embryos have a more limited ability to detect certain abnormalities than their somatic counterparts. Although direct proof for this assertion is still weak there is evidence in Xenopus embryos that the occurrence of cell cycle progression to the midblastula stage is not arrested either by the inhibition of DNA synthesis or by the presence of damaged DNA in the blastomeres (Kimelman et al., 1987; Gurdon, 1960) . In contrast, the classical experiments of Johnson and Rao (1971) clearly show that in heterokaryons, produced by fusion of two adult somatic cells at different cell-cycle stages, the onset of the next cell-cycle stage is delayed until both nuclei are synchronized. Thus, when an S-phase cell is fused to a G 2 -phase cell the onset of M-phase occurs only after the less advanced cell has completed S-phase and progressed to a point in G 2 at which both partners are permitted to enter M-phase. Likewise, when damaged DNA is introduced into somatic cells in the G 2 -phase, subsequent progression to M-phase remains blocked until DNA repair has been completed (see Weinert and Hartwell, 1988) . In this context it should be recalled that the capacity to repair DNA is common to both somatic cells and oocytes (Ashwood-Smith and Edwards, 1996) . Our studies paralleled those outlined above and aimed to determine whether oocytes and embryonic cells contain a series of G 2 -to M-phase checkpoints comparable to those present in somatic cells.
In an initial series of experiments the role of DNA damage checkpoints during the G 2 -to M-phase of meiosis was investi-gated. Bovine oocytes were irradiated with focused 254 nm UV light before the initiation of maturation (Bradshaw et al., 1995) . Following culture virtually all (Ͼ90%) of the control and irradiated oocytes underwent chromatin condensation and nuclear membrane breakdown irrespective of whether treated oocytes were matured in the presence or absence of inhibitors of DNA repair. These results are in direct contrast to those obtained in somatic cells where DNA damage invariably arrests cell cycle progression in the late G 2 phase (Maltzmann and Czyzyk, 1994) . Whilst it is apparent that the G 2 -to M-phase transition is not blocked by UV-induced DNA damage, further progression through metaphase does not occur because of aberrations to the spindle. The restricted ability of oocytes to detect aberrant DNA has been further confirmed recently by Pyrzynska et al. (1996) who showed that GV mouse oocytes, after premature fertilization, continued meiosis despite the presence of condensed sperm DNA.
A second series of experiments tested the hypothesis that G 2 -phase oocytes are capable of recognizing unreplicated or replicating DNA with the consequent arrest of meiosis before GVBD. Fully grown mouse oocytes at the GV-stage were maintained during manipulation in dbcAMP to prevent spontaneous nuclear membrane breakdown, and were then fused to early S-phase blastomeres from 4-cell stage embryos. After completion of fusion (1 h), hybrid cells were placed in normal medium and [ 3 H]-thymidine labelling was used to prove that DNA replication in the S-phase nucleus was not blocked in fused cells. Despite the presence of replicating DNA, GVBD was not prevented and chromosome condensation occurred in both the G 2 and S-phase nuclei. While the G 2 -set of chromosomes formed typical bivalents, the blastomere chromosomes formed S-phase prematurely condensed chromosomes. These results suggest that GV stage oocytes are unable to detect replicating DNA and undergo GVBD even in the presence of unreplicated chromatin (Fulka et al., 1995a) . In an extension of these studies, mouse oocytes were chemically enucleated in a method which caused them to eject the entire chromosome complement in the first polar body (Fulka and Moor, 1993) . These enucleated oocytes, which contained no chromosome condensation activity (CCA), were fused to S-phase cells. As before, the activation of MPF was not prevented by the presence of unreplicated DNA and S-phase chromosome condensation was detected (J.Fulka Jr, unpublished). The combined results from these two approaches show clearly that replication dependent checkpoints are either inactive or highly attenuated in fully grown mammalian oocytes.
Metaphase I checkpoint
It is possible that the apparent paucity of DNA responsive checkpoints in fully grown GV oocytes could be explained by the presence of checkpoints in the later phases of meiosis. The opportunity to investigate this arose from an observation, made during the establishment of our polyethyleneglycolinduced oocyte fusion procedure. The two sets of chromosomes in randomly fused mouse oocytes were always found at the same morphological stage; namely two metaphases, two anaphases or two telophases were invariably observed ( Figure  3 ). In analysing this interesting phenomenon further it was found that late metaphase I oocytes (cultured for 8 h), which had been fused to anaphase-telophase I oocytes (cultured for 8.5-9 h), always responded to signals from the cell at the more advanced meiotic cycle stage; two anaphases or two telophases were invariably detected in these hybrids ( Figure  3a) . Less advanced metaphase I oocytes (cultured for 6 h) prevented the onset of anaphase in more advanced metaphase I (8 h) fusion partners. Of even more interest is the finding that progression from anaphase I to telophase I was arrested or reversed (with the dispersal of chromosomes along the spindle) when early metaphase I (6 h) oocytes were fused to anaphase I oocytes (Figure 3b ). Fusion of a late metaphase I to a metaphase II oocytes did not prevent MI to AI progression whilst enabling the metaphase II set of chromosomes to progress into a metaphase III state (Fulka et al., 1995b) . Unexpected results were obtained in the late metaphase I fusion series. Normal synchronous meiosis continued when two oocytes in late metaphase I were fused (Figure 3c ). To determine whether late metaphase I oocytes recognize damaged 46 chromatin normal maturing oocytes (late MI) were fused with partners preincubated in etoposide (a topoisomerase II inhibitor which induces extensive chromatin clustering; Figure 3e ). After fusion, the chromosomes from the normal partner underwent normal anaphase, telophase and the extrusion of the first polar body whilst the etoposide-pretreated chromatin became extensively stretched and partitioned randomly between polar body and cytoplasm. Part of the chromatin was localized in the first polar body whilst the remainder was in the cytoplasm. Occasionally the chromatin connection between the polar body and the oocyte cytoplasm persisted (Fulka et al., 1997b) . These results were not anticipated and can be interpreted in the following manner. Before the mid-metaphase checkpoint, cell cycle regulators operate to control and synchronize cell progression when asynchronous cells are fused (earlyϫlate metaphase I). A particularly interesting situation develops after the midmaturation checkpoint. It appears both from our work on meiosis, and that of Rieder et al. (1997) on mitosis, that a signal to initiate anaphase is generated provided that one normal spindle is detected at the mid-maturation checkpoint. The signal to initiate anaphase appears to pervade the entire cell and overcomes inhibitory influences generated by hypercondensed chromatin or unattached kinetochores on additional spindles introduced by sperm penetration or by experimental cell fusion (Rieder et al., 1997; Fulka et al., 1997b) . Thus, in mammalian oocytes it is now clear that the progression of meiosis is not inhibited by the presence of an abnormal set of chromosomes provided only that a normal chromosome set is also present to provide the signal to initiate anaphase.
The transition from metaphase to anaphase and the segregation of homologous chromosomes (first meiotic division) or chromatids (second meiotic division) are the defining events of meiosis. Our results suggest that in normal oocytes the permission signals for segregation depend both upon the integrity of the spindle and upon the centromeric changes that precede chromatin separation. It is furthermore, well established that the degradation of MPF (assessed as H1 kinase activity) is an essential permissive step in the exit from metaphase in normal oocytes. Even when protein synthesis in metaphase I mouse oocytes has been inhibited using cycloheximide, the rapid decline in MPF activity, the entry into anaphase and first polar body extrusion occur normally. Thereafter, the metaphase chromosomes decondense and form an interphase nucleus. In contrast, when metaphase I mouse oocytes are treated firstly with etoposide to maintain tight binding of homologous chromosomes and then with cycloheximide the entire chromosome complement is extruded, after a significant 12 h delay, into an enlarged polar body. In these oocytes MPF degradation is extremely slow.
Similar results were obtained when metaphase II oocytes were treated with etoposide or colcemid. Thus, the inhibition of early events in chromatid separation (by etoposide treatment) and the absence of a normal spindle (due to expulsion following etoposide-cycloheximide treatment) lead to inhibition of MPF degradation and failure to exit from metaphases I and II (Fulka et al., 1994) . This has previously been shown by the in-vitro fertilization of nocodazole-treated oocytes (Schatten et al., 1985; Maro et al., 1986) .
The above experiments are important from another point of view also. The use of ICSI procedures in humans involves the direct injection of spermatozoa into oocytes. Even if no sperm head decondensation occurs it is possible that embryo development will continue, thus producing chromosomally abnormal cells. Clearly, the checkpoints studies are at an early stage and some additional experiments are necessary, but present findings show that maturing oocytes and early embryos have a limited capacity to recognize DNA damage and chromosomal abnormalities, as has also been discussed recently by Handyside and Delhanty (1997) .
DNA synthesis suppressing activity
The meiotic cycle progresses directly from metaphase I to metaphase II without an intervening interphase. Whilst this transition is logically required to decrease oocyte ploidy before fertilization, the underlying regulatory mechanisms are still unclear. Basically, three hypotheses have been advanced to explain this phenomenon (Cross et al., 1989) : (i) specific molecules directly regulate this transition; (ii) specific inhibiitors prevent decondensation of chromatin and thus DNA replication, or (iii) DNA synthesis after metaphase I does not occur because in meiosis I sister chromatids do not separate.
As illustrated above DNA replication is not prevented when S-phase nuclei are introduced into immature GV-staged oocytes (Fulka et al., 1995a) . When replicating nuclei were introduced into cytoplasts with no chromosome condensation activity (obtained from the bisection of maturing or matured nonactivated oocytes) nuclei remained intact but DNA replication ceased abruptly (Fulka et al., 1995c; Trefil et al., 1995) . Similarly, nuclei formed after the treatment of metaphase I oocytes with cycloheximide did not synthesize DNA. Even after the protein synthesis inhibitor was removed and these cells were cultured with dbc AMP it took a relatively long time before DNA replication could be detected (Clarke and Masui, 1984; Clarke et al., 1988) . The hypothesis that operation of the c-mos-mitogen-activated protein kinase (MAP) pathway prevents the decondensation of chromosomes and thus DNA synthesis after the exit from metaphase I, has been demonstrated in, e.g. Xenopus (Sagata, 1997) , but is no longer tenable, at least for mouse oocytes. In this species maturation continues almost normally up to metaphase II in c-mos-deficient mouse oocytes having also no detectable MAP kinase activity (Colledge et al., 1994; Hashimoto et al., 1994) . Interestingly, DNA replication has been detected both in nuclei formed in maturing mouse and pig oocytes after treatment with 6-dimethylamino purine (6-DMAP), a protein kinases inhibitor, and in mouse GV oocytes fused to anaphase-telophase II oocytes and thereafter incubated with 6-DMAP (Fulka et al., 1997a) . The results outlined above favour the hypothesis that certain specific inhibitor molecules (phosphatases) prevent DNA replication between metaphase I and II in mammalian oocytes. However, we recognize that additional factors may be involved in the regulation of this process. These findings will be important for cloning techniques in which maturing oocytes are used as the source of the cytoplast.
Conclusions
Since a comprehensive consideration of the entire field of oocyte maturation is impractical we have concentrated on reviewing the less understood aspects of the process. However, our focus should not obscure the fact that many aspects of the technique of oocyte maturation in vitro remain inadequate even though the first attempts to culture these cells occurred Ͼ60 years ago. The imperfections in the maturation system are observed most clearly in domestic animals and especially in the pig where development after fertilization is extremely low. Similarly, human oocytes complete meiosis, fertilize and undergo early cleavage in vitro but in almost all instances fail to develop after transfer to patients (Trounson et al., 1994) .
We have purposely highlighted aspects other than those already reviewed on components of maturation including meiotic cycle control (Masui and Clarke, 1979; Adashi and Leung, 1993; Sagata, 1996) , oocyte growth (Eppig and O'Brien, 1996) , follicle cell oocyte interactions (Moor and Crosby, 1986; Moor et al., 1996) and in-vitro maturation technology (Looney et al., 1994; Trounson et al., 1994; Galli and Lazzari, 1996) . It is our belief that the present review complements those already published and emphasizes the complexity of the oocyte maturation process. We believe further that it is only by considering all aspects of maturation that the production in vitro of mammalian eggs with a developmental potential equivalent to that of in-vivo counterparts will be achieved.
